trastuzumab
To view the entire topic, please log in or purchase a subscription.
Pediatrics Central™ is an all-in-one application that puts valuable medical information, via your mobile device or the web, in the hands of clinicians treating infants, children, and adolescents. Explore these free sample topics:
-- The first section of this topic is shown below --
General
High Alert Medication: This medication bears a heightened risk of causing significant patient harm when it is used in error.
Genetic Implications: 
Pronunciation:
traz-too-zoo-mab
To hear audio pronunciation of this topic, purchase a subscription or log in.Trade Name(s)
- Herceptin
- Herzuma
- Kanjinti
- Ogivri
- Ontruzant
- Trazimera
Ther. Class.
antineoplastics
Pharm. Class.
monoclonal antibodies
-- To view the remaining sections of this topic, please log in or purchase a subscription --
General
High Alert Medication: This medication bears a heightened risk of causing significant patient harm when it is used in error.
Genetic Implications:
Pronunciation:
traz-too-zoo-mab
To hear audio pronunciation of this topic, purchase a subscription or log in.Trade Name(s)
- Herceptin
- Herzuma
- Kanjinti
- Ogivri
- Ontruzant
- Trazimera
Ther. Class.
antineoplastics
Pharm. Class.
monoclonal antibodies
There's more to see -- the rest of this entry is available only to subscribers.